xRapid Foundation Information

xRapid is a world first in mobile health, it is the first commercially available app that has the functionality to quickly and accurately diagnose a major disease. By deploying cutting edge Digital Imaging technology and Artificial Intelligence, xRapid has brought a revolutionary diagnostic platform that can diagnose diseases such as Malaria faster, cheaper and more accurately than conventional methods. The test is accurate to a minimum of 98%, is consistent and reliable in its results as well as robust enough to cope with harsh climates and hot temperatures. Added to all of this, it is the lowest cost per test on the global market. The company has first developed xRapid-Malaria, an app that empowers health workers in the field and in laboratories. Using a system of pattern recognition, xRapid-Malaria can diagnose malaria from thick blood slides at the touch of a button. The technology streamlines the diagnostic process by providing an accessible solution for health workers. Malaria is a deadly global health problem, xRapid-Malaria gives much more people the means to test and treat the disease. xRapid is currently working on xRapid-Lab, a natural extension of their initial app to characterise the culture of Plasmodium. This automated counter for malaria culture supports all researchers working on lab culture of Plasmodium species by offering a new tool to count parasites and red blood cells faster. Story: xRapid is a Medtech company based primarily in London, UK with offices in Jakarta, Indonesia and San Francisco, USA. xRapid saw its beginnings in a laboratory in Jakarta. Our CTO, Professor David Mendels, recognised that he was able to develop a mobile solution for malaria diagnosis after attending a conference. Since then he has created xRapid; a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhoea.